Opill: FDA Approves First Nonprescription Birth Control Pill in the U.S.

The FDA has approved the first over-the-counter birth control pill in the United States, called Opill. This decision is a significant victory for medical groups advocating for easier access to contraception. Opill, also known as the "mini-pill," contains one hormone and is taken daily. It has been found to be 93% effective in preventing pregnancy with typical use. The over-the-counter availability is expected to remove barriers to access and reduce unintended pregnancies. Opill is anticipated to be available in early 2024, and its price is expected to be low since over-the-counter medications are typically not covered by insurance.